Small-Molecule 3D Ligand for RNA Recognition: Tuning Selectivity through Scaffold Hopping

S Felder, C Sagné, E Benedetti… - ACS Chemical Biology, 2022 - ACS Publications
Targeting RNAs with small molecules is considered the next frontier for drug discovery. In
this context, the development of compounds capable of binding RNA structural motifs of low …
被引用次数：2 相关文章

Small-Molecule 3D Ligand for RNA Recognition: Tuning Selectivity through Scaffold Hopping.

S Felder, C Sagné, E Benedetti, L Micouin - ACS Chemical Biology, 2022 - europepmc.org
Targeting RNAs with small molecules is considered the next frontier for drug discovery. In
this context, the development of compounds capable of binding RNA structural motifs of low …

Small-Molecule 3D Ligand for RNA Recognition: Tuning Selectivity through Scaffold Hopping

S Felder, C Sagné, E Benedetti… - ACS chemical …, 2022 - pubmed.ncbi.nlm.nih.gov
Targeting RNAs with small molecules is considered the next frontier for drug discovery. In
this context, the development of compounds capable of binding RNA structural motifs of low …

Small-Molecule 3D Ligand for RNA Recognition: Tuning Selectivity through Scaffold Hopping

S Felder, C Sagné, E Benedetti, L Micouin - ACS Chemical Biology, 2022 - cnrs.hal.science
Targeting RNAs with small molecules is considered the next frontier for drug discovery. In
this context, the develop-ment of compounds capable of binding RNA structural motifs of low …

Small-Molecule 3D Ligand for RNA Recognition: Tuning Selectivity through Scaffold Hopping

S Felder, C Sagné, E Benedetti, L Micouin - ACS Chemical Biology, 2022 - hal.science
Targeting RNAs with small molecules is considered the next frontier for drug discovery. In
this context, the develop-ment of compounds capable of binding RNA structural motifs of low …
[PDF] hal.science

[PDF][PDF] Small-Molecule 3D Ligand for RNA Recognition: Tuning Selectivity through Scaffold Hopping

S Felder, C Sagné, E Benedetti, L Micouin - hal.science
Targeting RNAs with small molecules is considered the next frontier for drug discovery. In
this context, the development of compounds capable of binding RNA structural motifs of low …